DC
ALNY icon

Deere & Company’s Alnylam Pharmaceuticals ALNY Stock Holding History

Deere & Company’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,551
Closed -$306K – 939
2015
Q2 		$306K Hold
2,551
– – 0.02% 766
2015
Q1 		$266K Hold
2,551
– – 0.01% 776
2014
Q4 		$247K Sell
2,551
-1,023
-29% -$94.8K 0.01% 791
2014
Q3 		$279K Hold
3,574
– – 0.02% 796
2014
Q2 		$226K Buy
+3,574
New +$212K 0.01% 809
2013
Q4 		– Sell
-7,684
Closed -$492K – 984
2013
Q3 		$492K Sell
7,684
-6,864
-47% -$342K 0.03% 659
2013
Q2 		$451K Buy
+14,548
New +$387K 0.03% 657

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Deere & Company's ALNY Position: Q3 2015 in Review

Deere & Company sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2015, closing a stake of 2,551 shares — an estimated $306K sold.

Deere & Company first reported a position in ALNY in Q2 2013 and held it in 7 quarters. The position peaked at $492K in Q3 2013. 258 funds tracked by Wall St. Rank hold ALNY as of Q3 2015.

  • Deere & Company reported no remaining Alnylam Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Deere & Company sold 2,551 Alnylam Pharmaceuticals shares in Q3 2015, an estimated $306K.
  • Deere & Company first reported a position in Alnylam Pharmaceuticals in Q2 2013 and held it in 7 quarters.
  • Deere & Company's Alnylam Pharmaceuticals position peaked at $492K in Q3 2013.
  • 258 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2015.

Based on Deere & Company's 13F filing for Q3 2015, filed 12 Nov 2015.